| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |